Precision financing for Durable/curative Therapies

Cell and gene therapies are transforming patients’ lives and payment models. This panel explores how downstream innovation is matching upstream scientific innovation to enable patient access. Hear how the NEWDIGS FoCUS consortium is tailoring performance-based annuities, subscription / “Netflix” models and other approaches to address the durability, payment timing and actuarial financial challenges of these new therapies.